Otros idiomas Shandong Boan Biotechnology Co., Ltd.

Acciones

6955

CNE100005RV4

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 10:08:28 24/05/2024			Varia. Cinco días.	Varia. 1 de enero.
9,44 ^HKD	-0,63 %		-5,32 %	-39,10 %

08/04	Shandong Boan Biotechnology completa el ensayo de fase 3 de su inyección para la retina	MT
08/04	Shandong Boan Biotechnology Co., Ltd. Completa el ensayo clínico de fase 3 en China para la inyección intravítrea de aflibercept (BA9101) y planea presentar la solicitud de licencia biológica	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Shandong Boan Biotechnology Co., Ltd. Enters into Loan Facility with China Jingu International Trust Co., Ltd	12/04
Shandong Boan Biotechnology Completes Phase 3 Trial for Retina Injection	08/04
Shandong Boan Biotechnology Co., Ltd. Completes Phase 3 Clinical Trial in China for Aflibercept Intravitreous Injection and Plans to Submit Biologics License Application	08/04
Ocumension Therapeutics' Eye Drug Completes Clinical Trials, to Apply for NDA Soon	08/04
Shandong Boan Biotechnology Trims Attributable Loss in 2023	26/03
Shandong Boan Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Shandong Boan Biotech Completes Phase 3 Trial for Type 2 Diabetes Injection; Shares Surge 10%	08/03
Shandong Boan Biotechnology Co., Ltd. Announces Phase 3 Clinical Trial Completed in China for Dulaglutide Injection	08/03
Shandong Boan Biotechnology Authorizes CDMO Service Provider to Use Stable Cell Line Development Platform	30/01
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with the Zencore Biologics Co., Ltd	30/01
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment	29/01
Shandong Boan Biotechnology Co., Ltd. Announces Orphan Drug Designations for Treatment of Gastric Cancer by FDA	24/01
Boan Biotechnology Secures Brazilian GMP Certification For Cancer Drug	18/01
Shandong Boan Biotechnology Co., Ltd. Obtains GMP Certification for Boyuno®? from the Brazilian Agencia Nacional De Vigilancia Sanitaria	17/01
Boan Biotech Completes Enrollment for International Multicenter Comparative Clinical (Phase 3) Study of Its Denosumab	12/01
Shandong Boan Enrolls Participants for Denosumab Injection Trials in EU, US and Japan	04/01
Certain H Shares of Shandong Boan Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 30-DEC-2023.	30/12
Shandong Boan Biotechnology Gets Orphan Drug Designations for Pancreatic Cancer Treatment	28/12
Shandong Boan Biotechnology Sells Equipment for Leaseback	26/12
Shandong Boan Biotechnology Co., Ltd. Announces Resignation of Chen Jie as Non-Executive Director	12/12

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Shandong Boan Biotechnology Co., Ltd.

Acciones

6955

CNE100005RV4

Otros idiomas

Filtros